Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Longitude Capital Partners IV, LLC's stake in Lexeo Therapeutics, Inc. fell to 3.80% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Longitude Capital Partners IV, LLC's stake in Lexeo Therapeutics, Inc. fell to 3.80%, 2,765,381 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 3.80%
- Shares
- 2,765,381
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Longitude Capital Partners IV, LLC | 3.80% | 2,765,381 |
| Longitude Venture Partners IV, L.P. | 3.80% | 2,765,381 |
| Patrick G. Enright | 3.80% | 2,765,381 |
| Juliet Tammenoms Bakker | 3.80% | 2,765,381 |
Source
Related
- Lexeo Therapeutics, Inc.
- Longitude Capital Partners IV, LLC
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026